West Family Investments Inc. Invests $551,000 in The Cooper Companies, Inc. $COO

West Family Investments Inc. bought a new position in The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 7,690 shares of the medical device company’s stock, valued at approximately $551,000.

Other institutional investors have also recently made changes to their positions in the company. New York Life Investment Management LLC increased its position in Cooper Companies by 0.6% during the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after purchasing an additional 158 shares during the period. Root Financial Partners LLC increased its position in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares in the last quarter. Essential Partners LLC raised its stake in Cooper Companies by 23.4% in the first quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock valued at $62,000 after buying an additional 166 shares during the last quarter. Allworth Financial LP raised its position in shares of Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after purchasing an additional 167 shares during the last quarter. Finally, SJS Investment Consulting Inc. raised its holdings in shares of Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after buying an additional 187 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on COO shares. Piper Sandler set a $86.00 target price on Cooper Companies and gave the stock an “overweight” rating in a report on Monday, June 1st. Weiss Ratings downgraded Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. Wells Fargo & Company reaffirmed a “sell” rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a research note on Wednesday, May 27th. Finally, Mizuho set a $85.00 price target on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $81.64.

Cooper Companies Trading Up 1.3%

Shares of COO stock opened at $76.73 on Thursday. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The company has a 50-day moving average of $71.59 and a two-hundred day moving average of $71.16. The firm has a market cap of $14.96 billion, a PE ratio of 65.03, a price-to-earnings-growth ratio of 1.98 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue was up 7.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.